ES8605036A1 - Procedimiento para desactivar un virus asociado a una frac- cion de plasma que contiene factor viii - Google Patents

Procedimiento para desactivar un virus asociado a una frac- cion de plasma que contiene factor viii

Info

Publication number
ES8605036A1
ES8605036A1 ES546920A ES546920A ES8605036A1 ES 8605036 A1 ES8605036 A1 ES 8605036A1 ES 546920 A ES546920 A ES 546920A ES 546920 A ES546920 A ES 546920A ES 8605036 A1 ES8605036 A1 ES 8605036A1
Authority
ES
Spain
Prior art keywords
heat treatment
plasma fractions
active substance
virus
substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES546920A
Other languages
English (en)
Other versions
ES546920A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alpha Therapeutic Corp
Original Assignee
Alpha Therapeutic Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpha Therapeutic Corp filed Critical Alpha Therapeutic Corp
Publication of ES546920A0 publication Critical patent/ES546920A0/es
Publication of ES8605036A1 publication Critical patent/ES8605036A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/04—Heat
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PROCEDIMIENTO PARA DESACTIVAR UN VIRUS ASOCIADO A UNA FRACCION DE PLASMA QUE CONTIENE FACTOR VIII. COMPRENDE LAS ETAPAS DE: A) DISPONER LA FRACCION DE PLASMA EN FORMA DE POLVO SECO; B) MEZCLAR EL POLVO SECO EN FRACCION DE PLASMA EN UN LIQUIDO ORGANICO, PARA FORMAR UNA SUSTANCIA DEL POLVO EN EL LIQUIDO; C) CALENTAR LA SUSPENSION FORMADA EN LA ETAPA B), A UNA TEMPERATURA ENTRE 60 Y 100JC, DURANTE UN PERIODO DE TIEMPO ELEGIDO, PARA DESACTIVAR ASI CUALQUIER VIRUS ASOCIADO A LA FRACCION DE PLASMA, AL TIEMPO QUE SE MANTIENE SUSTANCIALMENTE LA ACTIVIDAD BIOLOGICA DEL FACTOR VIII CONTENIDA EN LA FRACCION DE PLASMA; Y D) SEPARAR LA FRACCION DE PLASMA SUSPENDIDA DEL LIQUIDO ORGANICO, Y RECUPERAR LA FRACCION DE PLASMA SEPARADA.-
ES546920A 1983-12-02 1985-09-12 Procedimiento para desactivar un virus asociado a una frac- cion de plasma que contiene factor viii Expired ES8605036A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/557,665 US4490361A (en) 1983-12-02 1983-12-02 Virus inactivating heat treatment of plasma fractions

Publications (2)

Publication Number Publication Date
ES546920A0 ES546920A0 (es) 1986-02-16
ES8605036A1 true ES8605036A1 (es) 1986-02-16

Family

ID=24226390

Family Applications (2)

Application Number Title Priority Date Filing Date
ES537379A Granted ES537379A0 (es) 1983-12-02 1984-11-05 Un procedimiento para inactivar un virus asociado a un material biologico
ES546920A Expired ES8605036A1 (es) 1983-12-02 1985-09-12 Procedimiento para desactivar un virus asociado a una frac- cion de plasma que contiene factor viii

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES537379A Granted ES537379A0 (es) 1983-12-02 1984-11-05 Un procedimiento para inactivar un virus asociado a un material biologico

Country Status (7)

Country Link
US (1) US4490361A (es)
EP (1) EP0144709B1 (es)
JP (1) JPS60132919A (es)
KR (1) KR890000165B1 (es)
CA (1) CA1238580A (es)
DE (2) DE144709T1 (es)
ES (2) ES537379A0 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4615886A (en) * 1983-08-31 1986-10-07 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Utilizing a halohydrocarbon containing dissolved water to inactivate a lipid virus
DE3434472A1 (de) * 1984-09-20 1986-03-27 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Verfahren zur pasteurisation von plasmaproteinen bzw. von plasmaproteinfraktionen
US4639371A (en) * 1984-10-02 1987-01-27 New York Blood Center, Inc. Hepatitis B antigenic compositions and vaccines against hepatitis B derived therefrom
AT390374B (de) * 1986-03-18 1990-04-25 Schwab & Co Gmbh Verfahren zum pasteurisieren von plasmaprotein und plasmaproteinfraktionen
US4789545A (en) * 1986-03-31 1988-12-06 New York Blood Center, Inc. Removal of lipid soluble process chemicals from biological materials by extraction with naturally occurring oils or synthetic substitutes thereof
AT391809B (de) * 1988-01-12 1990-12-10 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutplasmaprodukten
USH1509H (en) * 1989-06-09 1995-12-05 Eran; Harutyun Heparin enhanced process for separating antihemophilic factor (Factor VIII) and fibronectin from cryoprecipitate
KR910005622B1 (ko) * 1989-11-22 1991-08-01 한국 식품개발 연구원 가축의 혈액을 이용한 분말 조미식품의 제조방법
AT402891B (de) * 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
DE4142908C2 (de) * 1991-12-24 1994-02-10 Octapharma Ag Glarus Verfahren zur Herstellung eines virusinaktivierten Prothrombinkomplex-Konzentrats (PPSB)
AT399818B (de) * 1992-04-24 1995-07-25 Immuno Ag Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation
WO1994013329A1 (de) * 1992-12-16 1994-06-23 Immuno Aktiengesellschaft Verfahren zur herstellung eines virussicheren biologischen präparates
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
DE4404625C2 (de) * 1994-02-14 1996-10-17 Ludwig Dr Baumgartner Verfahren zur Inaktivierung thermolabiler Viren in biologischem Material unter Beibehaltung der kollagenen Eigenschaften
US6632648B1 (en) 1996-05-14 2003-10-14 Elan Drug Delivery Limited Methods of terminal sterilization of fibrinogen
WO2004002412A2 (en) * 2002-06-26 2004-01-08 Pharmablood Inc. A method and composition to elicit an effective autologous antitumoral immune response in a patient
DE602005009677D1 (de) * 2004-03-22 2008-10-23 Solvay Pharm Gmbh Orale pharmazeutische zusammensetzungen von produkten mit lipase, insbesondere von pankreatin, mit tensiden
BRPI0614914A2 (pt) 2005-07-29 2011-04-19 Solvay Pharm Gmbh processos para a fabricação de pó de pancreatina esterilizada
US11266607B2 (en) * 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US9198871B2 (en) * 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US10072256B2 (en) * 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
FR2991582B1 (fr) * 2012-06-11 2014-06-13 Isp Investments Inc Extrait de fibres de coton et composition cosmetique et leur utilisation pour proteger, nourrir et hydrater la peau

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2405216A (en) * 1941-05-02 1946-08-06 Armour & Co Process for packaging surgical string material
US4031204A (en) * 1976-03-30 1977-06-21 Norden Laboratories, Inc. Feline viral rhinotracheitis vaccine and combination feline viral rhinotracheitis-calicivirus vaccine prepared therefrom
GB1590448A (en) * 1977-03-04 1981-06-03 Akzo Nv Vaccine and its preparations
DE2916711A1 (de) * 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
DE3043857A1 (de) * 1980-11-21 1982-07-08 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ii und vii
DE3045153A1 (de) * 1980-11-29 1982-07-08 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ix und x
US4456590B2 (en) * 1981-11-02 1989-05-30 Heat treatment of lyphilized blood clotting factor viii concentrate
US4511556A (en) * 1982-06-10 1985-04-16 The United States Of America As Represented By The Department Of Health And Human Services Inactivation of a lipid virus
JPS59501161A (ja) * 1982-06-10 1984-07-05 パ−セル・ロバ−ト・エツチ 脂質ウイルスの不活性化方法
CA1208551A (en) * 1982-12-27 1986-07-29 Ricardo H. Landaburu Solvent treatment of plasma protein products

Also Published As

Publication number Publication date
ES546920A0 (es) 1986-02-16
EP0144709A2 (en) 1985-06-19
KR890000165B1 (ko) 1989-03-09
CA1238580A (en) 1988-06-28
EP0144709A3 (en) 1985-07-03
EP0144709B1 (en) 1988-10-19
ES8603950A1 (es) 1986-01-01
DE3474635D1 (en) 1988-11-24
DE144709T1 (de) 1985-12-19
KR850004545A (ko) 1985-07-25
JPS60132919A (ja) 1985-07-16
ES537379A0 (es) 1986-01-01
US4490361A (en) 1984-12-25

Similar Documents

Publication Publication Date Title
ES8605036A1 (es) Procedimiento para desactivar un virus asociado a una frac- cion de plasma que contiene factor viii
ATE220929T1 (de) Behandlung von biologischen materialen vor der fixierung
DE3569473D1 (en) Method for inactivating pathogens in blood products
DE59209735D1 (de) Durch Hitze und/oder Detergens virusinaktiviertes Blutprodukt
ES2006389A6 (es) Procedimiento de tratamiento termico de trombina.
ES8503721A1 (es) "un metodo de inactivar un virus lipidico"
DE3374382D1 (en) Method of sterilizing utensils, particularly those made from thermolabile materials
GB1406789A (en) Surface sterilization
Anderson V. A Delayed Effect of X Rays on Pepsin
EP0954326A4 (en) PROCESS FOR INACTIVATION OF VIRUSES IN LYOPHILIZED BLOOD PROTEINS
ES2006632A6 (es) Procedimiento de tratamiento termico de fibrinogeno.
AU574869B2 (en) Textile coating
GB916351A (en) The production of nisin
DE69026512D1 (de) Stimulator von vaskulären endothelzellen und seine verwendung
JPS5359023A (en) Inactivation of toxins produced by microbials and attenuation of vaccines
Lovinger Insight revisited.
KR940010915A (ko) 즉석미의 제조방법
GB1092421A (en) Improvements relating to anticoagulant materials
Buddhadasa Interfaith Understanding in the Buddhist-Christian Dialogue
JPS5718621A (en) Treatment of hemolytic streptococcus having antitumor activity
Levin The content of components of the fibrinolytic system in the platelets of donor and fibrinolytic blood
SU1767975A1 (ru) Способ получения коклюшного антигенного комплекса
Jangg et al. Microstructure and Strength of Dispersion Hardened Al--Al 4 C 3-Materials and Influence of Heat Treatments
SU1468274A1 (ru) Способ получения таллия-199
MacDougal Periodicity in Trees